Kedar Hastak

Company: Personalis Inc

Job title: Associate Director, Applications Scientist

Seminars:

NeXT Personal™ for Ultra-sensitive Minimal Residual Disease (MRD) Detection & Response Monitoring 2:00 pm

NeXT Personal is an advanced tumor-informed liquid biopsy assay with superior sensitivity and specificity in measuring MRD Case studies in the Immunotherapy setting establish a strong correlation of NeXT Personal MRD with clinical outcome New clinical evidence from TRACERx demonstrates the significance of NeXT Personal in early-stage lung cancer and how ultra-sensitivity mattersRead more

day: Day One Track A PM